Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C4H6O3 |
| Molecular Weight | 102.0886 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC1COC(=O)O1
InChI
InChIKey=RUOJZAUFBMNUDX-UHFFFAOYSA-N
InChI=1S/C4H6O3/c1-3-2-6-4(5)7-3/h3H,2H2,1H3
| Molecular Formula | C4H6O3 |
| Molecular Weight | 102.0886 |
| Charge | 0 |
| Count |
|
| Stereochemistry | RACEMIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Optical Activity | ( + / - ) |
Propylene carbonate is a cyclic carbonate that reacts with amines to form carbamates, undergoes hydroxy alkylation and transesterification. It can be used as an isocyanate and unsaturated polyester resin cleanup solvent, viscosity reducer in coatings, CO2 extraction solvent, electrolyte in lithium batteries, polar additive for clay gellants, foundry binder catalyst, and textile dye carrier and cleaner. In cosmetics and personal care products, Propylene Carbonate is used in the formulation of makeup, primarily lipstick, eye shadow, and mascara, as well as in skin cleansing products.
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| FTIR, FT-Raman, ab initio and density functional studies on 4-methyl-1,3-dioxolan-2-one and 4,5-dichloro-1,3-dioxolan-2-one. | 2010-09-15 |
|
| Is the general conclusion justified that higher applicable field strength results in shorter analysis time with organic solvents in CE? | 2009-11 |
|
| Solvent effect on the sensitized photooxygenation of 2,3-dihydropyrazine derivatives. | 2003-04-18 |
|
| Lead as its own luminescent sensor. | 2002-12-30 |
Sample Use Guides
In Vivo Use Guide
Curator's Comment: Gavage studies in rats for 90 days at concentrations of up to 5,000 mg/kg/d did not induce any significant toxic effects.
Rats: Daily application of 10.5 or 17.5% propylene carbonate in physiological saline to the skin of rats for 1 month produced hyperkeratosis and an increase in the number of basal epithelial cells at the treatment site.
Route of Administration:
Topical
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 17:33:08 GMT 2025
by
admin
on
Mon Mar 31 17:33:08 GMT 2025
|
| Record UNII |
8D08K3S51E
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
203-572-1
Created by
admin on Mon Mar 31 17:33:08 GMT 2025 , Edited by admin on Mon Mar 31 17:33:08 GMT 2025
|
PRIMARY | |||
|
PROPYLENE CARBONATE
Created by
admin on Mon Mar 31 17:33:08 GMT 2025 , Edited by admin on Mon Mar 31 17:33:08 GMT 2025
|
PRIMARY | |||
|
108-32-7
Created by
admin on Mon Mar 31 17:33:08 GMT 2025 , Edited by admin on Mon Mar 31 17:33:08 GMT 2025
|
PRIMARY | |||
|
7924
Created by
admin on Mon Mar 31 17:33:08 GMT 2025 , Edited by admin on Mon Mar 31 17:33:08 GMT 2025
|
PRIMARY | |||
|
SUB12565MIG
Created by
admin on Mon Mar 31 17:33:08 GMT 2025 , Edited by admin on Mon Mar 31 17:33:08 GMT 2025
|
PRIMARY | |||
|
C045990
Created by
admin on Mon Mar 31 17:33:08 GMT 2025 , Edited by admin on Mon Mar 31 17:33:08 GMT 2025
|
PRIMARY | |||
|
DTXSID2026789
Created by
admin on Mon Mar 31 17:33:08 GMT 2025 , Edited by admin on Mon Mar 31 17:33:08 GMT 2025
|
PRIMARY | |||
|
C76729
Created by
admin on Mon Mar 31 17:33:08 GMT 2025 , Edited by admin on Mon Mar 31 17:33:08 GMT 2025
|
PRIMARY | |||
|
1576504
Created by
admin on Mon Mar 31 17:33:08 GMT 2025 , Edited by admin on Mon Mar 31 17:33:08 GMT 2025
|
PRIMARY | |||
|
CHEMBL1733973
Created by
admin on Mon Mar 31 17:33:08 GMT 2025 , Edited by admin on Mon Mar 31 17:33:08 GMT 2025
|
PRIMARY | |||
|
6806
Created by
admin on Mon Mar 31 17:33:08 GMT 2025 , Edited by admin on Mon Mar 31 17:33:08 GMT 2025
|
PRIMARY | |||
|
1363696
Created by
admin on Mon Mar 31 17:33:08 GMT 2025 , Edited by admin on Mon Mar 31 17:33:08 GMT 2025
|
PRIMARY | RxNorm | ||
|
C45678
Created by
admin on Mon Mar 31 17:33:08 GMT 2025 , Edited by admin on Mon Mar 31 17:33:08 GMT 2025
|
CONCEPT | Industrial Aid | ||
|
8D08K3S51E
Created by
admin on Mon Mar 31 17:33:08 GMT 2025 , Edited by admin on Mon Mar 31 17:33:08 GMT 2025
|
PRIMARY | |||
|
8D08K3S51E
Created by
admin on Mon Mar 31 17:33:08 GMT 2025 , Edited by admin on Mon Mar 31 17:33:08 GMT 2025
|
PRIMARY | |||
|
100000078539
Created by
admin on Mon Mar 31 17:33:08 GMT 2025 , Edited by admin on Mon Mar 31 17:33:08 GMT 2025
|
PRIMARY | |||
|
11784
Created by
admin on Mon Mar 31 17:33:08 GMT 2025 , Edited by admin on Mon Mar 31 17:33:08 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
ENANTIOMER -> RACEMATE |
|
||
|
ENANTIOMER -> RACEMATE |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
